Cited by 1,192Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Friberg, Leif, Rosenqvist, Mårten, Lip, Gregory Y.H.·2012·European Heart Journal

DOI 10.1093/eurheartj/ehr488

Open this paper in CoChat — free account

Abstract

Aims The impact of some risk factors for stroke and bleeding, and the value of stroke and bleeding risk scores, in atrial fibrillation (AF), has been debated, as clinical trial cohorts have not adequately tested these. Our objective was to investigate risk factors for stroke and bleeding in AF, and application of the new CHA(2)DS(2)-VASc and HAS-BLED schemes for stroke and bleeding risk assessments, respectively. Methods and results We used the Swedish Atrial Fibrillation cohort study, a nationwide cohort study of 182 678 subjects with a diagnosis of AF at any Swedish hospital between 1 July 2005 and 31 December 2008, who were prospectively followed for an average of 1.5 years (260 000 years at risk). With the use of the National Swedish Drug Registry, all patients who used an oral anticoagulant anytime during follow-up were identified. Most of the analyses were made on a subset of 90 490 patients who never used anticoagulants. Risk factors for stroke, the composite thromboembolism endpoint (stroke, TIA, or systemic embolism), and bleeding, and the performance of published stroke and bleeding risk stratification schemes were investigated. On multivariable analysis, significant associations were found between the following 'new' risk factors and thromboembolic events; peripheral artery disease [hazard ratio (HR) 1.22 (95% CI 1.12-1.32)], 'vascular disease' [HR 1.14 (1.06-1.23)], prior myocardial infarction [HR 1.09 (1.03-1.15)], and female gender [HR 1.17 (1.11-1.22)]. Previou…

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehr488

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citation
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,954
Self-citation
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
Self-citation
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina, R. B. D'Agostino Sr, R. B. D'Agostino Jr, R. S. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929)
Greenland, P. (2007) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.024 · Cited by 1,077
Self-citation

Show all 48 references

Research works printed but not linked: 2

Atrial Fibrillation Investigators, 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomised clinical trials, Arch Intern Med, 154, 1949
National Collaborating Centre for Chronic Conditions, 2006, Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care

Sorted by citations

Items 101–200 of 999

New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people
Holt, A., Gislason, G., Schou, M., Zareini, B., Biering‐Sørensen, T., Phelps, M. D., Kragholm, K. H., Andersson, C., Fosbøl, E. L., Hansen, M. L., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa494 · Cited by 111
Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence
Nadeau, S. E., Wu, J. K., & Lawhern, R. A. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.721357 · Cited by 121
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Meier, B., Blaauw, Y., Khattab, A. A., Lewalter, T., Sievert, H., Tondo, C., & Glikson, M. (2015) · EuroIntervention · doi:10.4244/eijy14m09_18 · Cited by 110
Contemporary Atrial Fibrillation Management: A Comparison of the Current AHA/ACC/HRS, CCS, and ESC Guidelines
Andrade, J. G., Macle, L., Nattel, S., Verma, A., & Cairns, J. A. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.06.002 · Cited by 107
Anticoagulation in atrial fibrillation
Steinberg, B. A., & Piccini, J. P. (2014) · BMJ · doi:10.1136/bmj.g2116 · Cited by 104
Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation
Friberg, L., Andersson, T., & Rosenqvist, M. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz304 · Cited by 107
Self-citation
CHA 2 DS 2 -VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65–74, Female) for Stroke in Asian Patients With Atrial Fibrillation
Kim, T., Yang, P., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., & Lip, G. Y. H. (2017) · Stroke · doi:10.1161/strokeaha.117.016926 · Cited by 104
Self-citation
Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality
Kanwal, F., Taylor, T. J., Kramer, J. R., Cao, Y., Smith, D. L., Gifford, A. L., El‐Serag, H. B., Naik, A. D., & Asch, S. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.23780 · Cited by 107
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316676037 · Cited by 104
Self-citation
New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness
Mani, H., & Lindhoff‐Last, E. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s45644 · Cited by 101
Reliable Identification of “Truly Low” Thromboembolic Risk in Patients Initially Diagnosed With “Lone” Atrial Fibrillation
Potpara, T., Polovina, M. M., Licina, M. M., Marinković, J., Prostran, M. S., & Lip, G. Y. H. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966713 · Cited by 102
Self-citation
Trends in Hospitalization for Atrial Fibrillation: Epidemiology, Cost, and Implications for the Future
Sheikh, A. B., Patel, N., Nalluri, N., Agnihotri, K., Spagnola, J., Patel, A., Asti, D., Kanotra, R., Khan, H., Savani, C., et al. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.002 · Cited by 99
D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial
Christersson, C., Wallentin, L. C., Andersson, U., Alexander, J. H., Ansell, J., Caterina, R. D., Gersh, B. J., Granger, C. B., Hanna, M., Horowitz, J. D., et al. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12638 · Cited by 103
Validation of CHA2DS2-VASc and HAS-BLED Scores in Japanese Patients With Nonvalvular Atrial Fibrillation
Okumura, K., Inoue, H., Atarashi, H., Yamashita, T., Tomita, H., Origasa, H., & for the J-RHYTHM Registry Investigators. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0144 · Cited by 100
Quality indicators for the care and outcomes of adults with atrial fibrillation
Arbelo, E., (Chair), Aktaa, S., Bollmann, A., d’Ávila, A., Drossart, I., Dwight, J., Hills, M. T., Hindricks, G., Kusumoto, F. M., et al. (2020) · EP Europace · doi:10.1093/europace/euaa253 · Cited by 100
Self-citation
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis
Gorog, D. A., Ferreiro, J. L., Ahrens, I., Ako, J., Geisler, T., Halvorsen, S., Huber, K., Jeong, Y., Navarese, E. P., Rubboli, A., et al. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00901-2 · Cited by 100
Self-citation
Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug
Santoro, G., Meucci, F., Stolcova, M., Rezzaghi, M., Mori, F., Palmieri, C., Paradossi, U., Pastormerlo, L. E., Rosso, G., & Berti, S. (2016) · EuroIntervention · doi:10.4244/eijy14m10_12 · Cited by 97
Sex Differences in Atrial Fibrillation
Andrade, J. G., Deyell, M. W., Lee, A. K. Y., & Macle, L. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.11.022 · Cited by 100
2019 Chinese guideline for the management of hypertension in the elderly.
Hua, Q., Fan, L. H., & Li, J. (2019) · PubMed Central · doi:10.11909/j.issn.1671-5411.2019.02.001 · Cited by 97
Dabigatran use in elderly patients with atrial fibrillation
Avgil-Tsadok, M., Jackevicius, C. A., Essebag, V., Eisenberg, M. J., Rahme, E., Behlouli, H., & Pilote, L. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-03-0247 · Cited by 95
Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management
Gumprecht, J. J., Domek, M., Lip, G. Y. H., & Shantsila, A. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0279-7 · Cited by 98
Self-citation
Study of molecular events in cells by fluorescence correlation spectroscopy
Vukojević, V. B., Pramanik, A., Yakovleva, T., Rigler, R. W., Terenius, L. Y., & Bakalkin, G. Y. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4305-7 · Cited by 94
ESC working group on e-cardiology position paper: use of commercially available wearable technology for heart rate and activity tracking in primary and secondary cardiovascular prevention—in collaboration with the European Heart Rhythm Association, European Association of Preventive Cardiology, Association of Cardiovascular Nursing and Allied Professionals, Patient Forum, and the Digital Health Committee
Jensen, M. T., Treskes, R. W., Caiani, E. G., Casado-Arroyo, R., Cowie, M. R., Dilaveris, P., Duncker, D., Di Rienzo, M., Frederix, I., De Groot, N., et al. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab011 · Cited by 93
Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies
Roskell, N. S., Samuel, M., Noack, H., & Monz, B. U. (2013) · EP Europace · doi:10.1093/europace/eut001 · Cited by 91
Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes
Dzeshka, M. S., Shahid, F., Shantsila, A., & Lip, G. Y. H. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx013 · Cited by 91
Self-citation
Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients
Ashburner, J. M., Go, A. S., Chang, Y., Fang, M. C., Fredman, L., Applebaum, K. M., & Singer, D. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.080 · Cited by 91
Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry
Wintgens, L. I. S., Romanov, A., Phillips, K. P., Ballesteros, G., Swaans, M. J., Folkeringa, R., García‐Bolao, I., Pokushalov, E., & Boersma, L. V. A. (2018) · EP Europace · doi:10.1093/europace/euy025 · Cited by 89
CT sizing for left atrial appendage closure is associated with favourable outcomes for procedural safety
Rajwani, A., Nelson, A. J., Shirazi, M. G., DISNEY, P. J. S., Teo, K. S. L., Wong, D. T. L., Young, G. D., & Worthley, S. G. (2016) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jew212 · Cited by 89
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/29/1560-4071-2020-4083 · Cited by 88
Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study
Overvad, T. F., Skjøth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015) · Stroke · doi:10.1161/strokeaha.115.009371 · Cited by 87
Self-citation
Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?
Lip, G. Y. H., Rushton-Smith, S. K., Goldhaber, S. Z., Fitzmaurice, D. A., Mantovani, L. G., Goto, S., Haas, S. K., Bassand, J., Camm, A. J., Ambrosio, G., et al. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001556 · Cited by 84
Self-citation
A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · CHEST Journal · doi:10.1378/chest.13-2103 · Cited by 87
Self-citation
Stroke in atrial fibrillation: Review of risk stratification and preventive therapy
Alshehri, A. (2019) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_99_18 · Cited by 93
Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
Alberts, M. J., Eikelboom, J. W., & Hankey, G. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70258-2 · Cited by 80
Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: Experience from the Stockholm health care system
Forslund, T., Wettermark, B., Wändell, P. E., von Euler, M., Hasselström, J., & Hjemdahl, P. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.063 · Cited by 82
Meta-Analysis of CHADS2 versus CHA2DS2-VASc for Predicting Stroke and Thromboembolism in Atrial Fibrillation Patients Independent of Anticoagulation
Zhu, W., Xiong, Q., & Hong, K. (2015) · Texas Heart Institute Journal · doi:10.14503/thij-14-4353 · Cited by 82
Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure
Savarese, G., Giugliano, R. P., Rosano, G. M. C., McMurray, J. J. V., Magnani, G., Filippatos, G. S., Dellegrottaglie, S., Lund, L. H., Trimarco, B., & Filardi, P. P. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2016.07.012 · Cited by 81
Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation
Guo, Y., Apostolakis, S. Z., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., & Lip, G. Y. H. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.052 · Cited by 80
Self-citation
Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure
López-Mínguez, J. R., Nogales‐Asensio, J. M., Gragera, J. E., Costa, M. A. D. S., Cruz‐González, I., de Carlos, F. G., Díaz, J. A. F., Yuste, V. M., González, R. M., Domínguez-Franco, A. J., et al. (2015) · Heart · doi:10.1136/heartjnl-2014-306332 · Cited by 79
Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call?
Manolis, A. S., Manolis, T. A., Melita, H., & Manolis, A. S. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.02.011 · Cited by 81
Assessing the Risk of Bleeding in Patients With Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Lagrenade, I., Lane, D. A., Taillandier, S., & Fauchier, L. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.972869 · Cited by 78
Self-citation
Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism
Wintzer-Wehekind, J., Alperi, A., Houde, C., Côté, J., Asmarats, L., Côté, M., & Rodés‐Cabau, J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.061 · Cited by 78
Atrial fibrillation, cognitive impairment, and neuroimaging
Graff‐Radford, J., Madhavan, M., Vemuri, P., Rabinstein, A. A., Cha, R. H., Mielke, M. M., Kantarci, K., Lowe, V. J., Senjem, M. L., Gunter, J. L., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.08.164 · Cited by 79
Lack of Concordance Between Empirical Scores and Physician Assessments of Stroke and Bleeding Risk in Atrial Fibrillation
Steinberg, B. A., Kim, S., Thomas, L. E., Fonarow, G. C., Hylek, E. M., Ansell, J., Go, A. S., Chang, P., Kowey, P. R., Gersh, B. J., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.008643 · Cited by 74
New Oral Anticoagulants Are Not Superior to Warfarin in Secondary Prevention of Stroke or Transient Ischemic Attacks, but Lower the Risk of Intracranial Bleeding: Insights from a Meta-Analysis and Indirect Treatment Comparisons
Sardar, P., Chatterjee, S., Wu, W., Lichstein, E., Ghosh, J., Aikat, S., & Mukherjee, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077694 · Cited by 73
Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage
Horstmann, S., Zugck, C., Krumsdorf, U., Rizos, T., Rauch, G., Geis, N. A., Hardt, S. E., & Veltkamp, R. C. (2013) · Neurology · doi:10.1212/wnl.0000000000000022 · Cited by 72
Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation
Hori, M., Matsumoto, M., Tanahashi, N., Momomura, S., Uchiyama, S., Goto, S., Izumi, T., Koretsune, Y., Kajikawa, M., Kato, M. C., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-0899 · Cited by 71
The Impact of Heart Failure and Left Ventricular Dysfunction in Predicting Stroke, Thromboembolism, and Mortality in Atrial Fibrillation Patients: A Systematic Review
Agarwal, M., Apostolakis, S. Z., Lane, D. A., & Lip, G. Y. H. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.015 · Cited by 68
Self-citation
Sex differences in the inflammatory response to stroke
Tariq, M. B., Lee, J., & McCullough, L. D. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00969-x · Cited by 72
Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: A nationwide cohort study of 9519 patients
Andersson, T., Magnuson, A., Bryngelsson, I.-L., Frøbert, O., Henriksson, K. M., Edvardsson, N., & Poçi, D. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.092 · Cited by 68
Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation
Desteghe, L., Vijgen, J. M., Koopman, P., Dilling-Boer, D. M., Schurmans, J., Dendale, P., & Heidbüchel, H. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx762 · Cited by 70
Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis
Caldeira, D., Costa, J. N., Fernandes, R. M., Pinto, F. J., & Ferreira, J. J. (2014) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9930-y · Cited by 67
Meta-Analysis of the Influence of Chronic Kidney Disease on the Risk of Thromboembolism Among Patients With Nonvalvular Atrial Fibrillation
Providencia, R. A., Marijon, É., Bovéda, S., Barra, S., Narayanan, K., Heuzey, J. L., Gersh, B. J., & Gonçalves, L. M. M. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.05.048 · Cited by 67
Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
Lee, S., Mullin, R., Blazawski, J., & Coleman, C. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047473 · Cited by 66
Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry
Phillips, K. P., Romanov, A., Николаевич, А. С., Folkeringa, R., Szili‐Törok, T., Senatore, G., Steín, K. M., Omar, R., Gordon, N. T., & Boersma, L. V. A. (2019) · EP Europace · doi:10.1093/europace/euz286 · Cited by 66
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation
Ganse, E. H. V., Danchin, N., Mahé, I., Hanon, O., Jacoud, F., Nolin, M., Dalon, F., Lefèvre, C., Cotté, F.-E., Gollety, S., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.028825 · Cited by 66
Factors Driving Anticoagulant Selection in Patients With Atrial Fibrillation in the United States
Lauffenburger, J. C., Farley, J. F., Gehi, A. K., Rhoney, D. H., Brookhart, M. A., & Fang, G. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.539 · Cited by 67
Assessment of Use vs Discontinuation of Oral Anticoagulation After Pulmonary Vein Isolation in Patients With Atrial Fibrillation
Själander, S., Holmqvist, F., Smith, J. G., Platonov, P. G., Kesek, M., Svensson, P. J., Blomström‐Lundqvist, C., Tabrizi, F., Tapanainen, J. M., Poçi, D., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.4179 · Cited by 64
European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care
Hobbs, R. F., Taylor, C. J., Geersing, G. J., Rutten, F. H., Brouwer, J. R., & on behalf of the European Primary Care Cardiovascular Society (EPCCS) SPAF working group (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315571890 · Cited by 67
The Social Vulnerability Index and Long-term Outcomes After Traumatic Injury
Herrera‐Escobar, J. P., Uribe‐Leitz, T., Wang, Y., Orlas, C. P., Moheb, M. N. E., Lamarre, T. E., Ahmad, N., Hau, K. M., Jarman, M. P., Levy‐Carrick, N. C., et al. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005471 · Cited by 64
Bleeders, bleeding rates, and bleeding score
Tosetto, A., Castaman, G., & Rodeghiero, F. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12248 · Cited by 66
Rivaroxaban vs. Warfarin in Japanese Patients With Non-Valvular Atrial Fibrillation in Relation to Age
Hori, M., Matsumoto, M., Tanahashi, N., Momomura, S., Uchiyama, S., Goto, S., Izumi, T., Koretsune, Y., Kajikawa, M., Kato, M. C., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1324 · Cited by 64
Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials
Sahay, S., y, L. N.-F., Rodés‐Cabau, J., Jiménez‐Quevedo, P., Salinas, P., Biagioni, C., Nuñez-Gil, I. J., Gonzalo, N., de Agustín, J. A., Trigo, M. D., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-309782 · Cited by 64
Stroke risk stratification in atrial fibrillation: a review of common risk factors
Oladiran, O. D., & Nwosu, I. F. (2019) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2019.1593781 · Cited by 69
Gender and contemporary risk of adverse events in atrial fibrillation
Champsi, A., Mobley, A., Subramanian, A., Nirantharakumar, K., Wang, X., Shukla, D., Bunting, K. V., Moelgaard, I., Dwight, J., Casado-Arroyo, R., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae539 · Cited by 65
Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project
Lord, J. L., Willis, S., Eatock, J., Tappenden, P., Trapero‐Bertran, M., Miners, A. H., Crossan, C., Westby, M. J., Anagnostou, A., Taylor, S. J. E., et al. (2013) · Health Technology Assessment · doi:10.3310/hta17580 · Cited by 61
Clinical Significance of the Assessment of the Systolic and Diastolic Myocardial Function of the Left Atrium in Patients With Paroxysmal Atrial Fibrillation and Low CHADS2 Index Treated With Catheter Ablation Therapy
Morris, D. A., Parwani, A. S., Huemer, M., Wutzler, A., Bekfani, T., Attanasio, P., Friedrich, K., Kühnle, Y., Haverkamp, W., & Boldt, L. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.021 · Cited by 60
Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation
Shah, S. J., Singer, D. E., Fang, M. C., Reynolds, K., Go, A. S., & Eckman, M. H. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.006212 · Cited by 60
Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?
Olesen, J. B., & Torp-Pedersen, C. T. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-02-0154 · Cited by 59
Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
Best, J. G., Ambler, G., Wilson, D., Lee, K., Lim, J., Shiozawa, M., Koga, M., Li, L., Lovelock, C. E., Chabriat, H., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00024-7 · Cited by 59
Self-citation
Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation
Tsadok, M. A., Jackevicius, C. A., Rahme, E., Humphries, K. H., & Pilote, L. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001398 · Cited by 59
Left atrial appendage closure using AMPLATZER™ devices: A large, multicenter, Italian registry
Berti, S. L., Santoro, G., Brscic, E., Montorfano, M., Vignali, L., Danna, P., Tondo, C., D’Amico, G., Stabile, A., Saccà, S., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.052 · Cited by 59
Risk of Arterial Ischemic Events after Intracerebral Hemorrhage
Murthy, S., Díaz, I., Wu, X., Merkler, A., Iadecola, C., Safford, M., Sheth, K., Navi, B., & Kamel, H. (2019) · Stroke · doi:10.1161/strokeaha.119.026207 · Cited by 61
Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists
Bertoméu, V., Cequier, A. R., Marín, F. R., Anguita, M. P., & Ortiz, M. R. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-02-0169 · Cited by 58
Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study
Fauchier, L., Samson, A., Chaize, G., Gaudin, A.-F., Vainchtock, A., Bailly, C., & Cotté, F.-E. (2015) · Open Heart · doi:10.1136/openhrt-2015-000290 · Cited by 58
Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study
Bergmann, M., İnce, H., Kische, S., Schmitz, T., Meincke, F., Schmidt, B., Foley, D., Betts, T. R., Grygier, M., Protopopov, A. V., et al. (2018) · EuroIntervention · doi:10.4244/eij-d-17-00672 · Cited by 58
Stroke prevention strategies in high-risk patients with atrial fibrillation
Kotalczyk, A., Mazurek, M., Kalarus, Z. F., Potpara, T., & Lip, G. Y. H. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00459-3 · Cited by 60
Self-citation
Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk‐Score Acronyms (CHADS 2 , CHA 2 DS 2 ‐VASc, R 2 CHADS 2 , HAS‐BLED, ATRIA, and More)
Dzeshka, M. S., Lane, D. A., & Lip, G. Y. H. (2014) · Clinical Cardiology · doi:10.1002/clc.22294 · Cited by 57
Self-citation
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
Hess, P. L., Mirro, M. J., Diener, H., Eikelboom, J. W., Al‐Khatib, S. M., Hylek, E. M., Bosworth, H. B., Gersh, B. J., Singer, D. E., Flaker, G., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.04.007 · Cited by 58
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
Sulzgruber, P., Waßmann, S., Semb, A. G., Doehner, W., Widimský, P., Gremmel, T., Kaski, J. C., Savarese, G., Rosano, G. M. C., Borghi, C., et al. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz016 · Cited by 58
Net Clinical Benefit of Warfarin Therapy in Elderly Chinese Patients With Atrial Fibrillation
Siu, C., & Tse, H. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000858 · Cited by 56
Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis
Chan, P., Huang, D., Yip, P.-S., Hai, J. J., Tse, H., Chan, T. M., Lip, G. Y. H., Lo, W.-K., & Siu, C. (2015) · EP Europace · doi:10.1093/europace/euv289 · Cited by 55
Self-citation
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation
Eckman, M. H., Lip, G. Y. H., Wise, R. E., Speer, B. B., Sullivan, M., Walker, N., D, B. M. K. M., Flaherty, M. L., Kleindorfer, D., Baker, P., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.02.009 · Cited by 56
Self-citation
Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and left appendage thrombus: feasibility, safety and clinical efficacy
Tarantini, G., D’Amico, G., Latib, A., Montorfano, M., Mazzone, P., Fassini, G. M., Maltagliati, A. C., Ronco, F., Saccà, S., Cruz‐González, I., et al. (2018) · EuroIntervention · doi:10.4244/eij-d-17-00777 · Cited by 56
Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study
Lawal, O. D., Aronow, H. D., Shobayo, F. O., Hume, A. L., Taveira, T. H., Matson, K. L., Zhang, Y., & Wen, X. (2023) · Circulation · doi:10.1161/circulationaha.122.060687 · Cited by 54
Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke
Yong, J. H. E., Thavorn, K., Hoch, J. S., Mamdani, M., Thorpe, K. E., Dorian, P., Sharma, M., Laupacis, A., & Gladstone, D. J. (2016) · Stroke · doi:10.1161/strokeaha.115.011979 · Cited by 54
Performance of bleeding risk scores in dialysis patients
Ocak, G., Ramspek, C. L., Rookmaaker, M. B., Blankestijn, P. J., Verhaar, M. C., Bos, W. J. W., Dekker, F. W., & van Diepen, M. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy387 · Cited by 53
Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
Proietti, M., Senoo, K., Lane, D. A., & Lip, G. Y. H. (2016) · Scientific Reports · doi:10.1038/srep24376 · Cited by 53
Self-citation
Arrhythmias in Female Patients: Incidence, Presentation and Management
Zeitler, E. P., Poole, J. E., Albert, C. M., Al-Khatib, S. M., Ali-Ahmed, F., Birgersdotter-Green, U., Cha, Y.-M., Chung, M. K., Curtis, A. B., Hurwitz, J. L., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319893 · Cited by 57
Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives
Landmesser, U., Skurk, C., Tzikas, A., Falk, V., Reddy, V. Y., & Windecker, S. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae398 · Cited by 56
Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation
Nielsen, P. B., Larsen, T. B., Gorst‐Rasmussen, A., Skjøth, F., Rasmussen, L. H., & Lip, G. Y. H. (2014) · CHEST Journal · doi:10.1378/chest.14-2099 · Cited by 53
Self-citation
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF])
Cherian, T. S., Shrader, P. J., Fonarow, G. C., Allen, L. A., Piccini, J. P., Peterson, E. D., Thomas, L. E., Kowey, P. R., Gersh, B. J., & Mahaffey, K. W. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.02.050 · Cited by 53
Relationship of Hypertension and Systolic Blood Pressure With the Risk of Stroke or Bleeding in Patients With Atrial Fibrillation: The Fushimi AF Registry
Ishii, M., Ogawa, H., Unoki, T., An, Y., Iguchi, M., Masunaga, N., Esato, M., Chun, Y., Tsuji, H., Wada, H., et al. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx094 · Cited by 53
Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation
Kim, T., Yang, P., Yu, H. T., Jang, E., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., & Lip, G. Y. H. (2018) · Stroke · doi:10.1161/strokeaha.118.021047 · Cited by 53
Self-citation
Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?
Agnelli, G., & Paciaroni, M. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-08-0667 · Cited by 52
A Simple and Portable Algorithm for Identifying Atrial Fibrillation in the Electronic Medical Record
Khurshid, S. S., Keaney, J., Ellinor, P. T., & Lubitz, S. A. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.10.031 · Cited by 52
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations
Imberti, J. F., Mei, D. A., Vitolo, M., Bonini, N., Proietti, M., Potpara, T., Lip, G. Y. H., & Boriani, G. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.04.023 · Cited by 51
Self-citation
Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic
Hajhosseiny, R., Matthews, G. D. K., & Lip, G. Y. H. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.06.038 · Cited by 53
Self-citation
Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities
Dobesh, P. P., & Fanikos, J. R. (2015) · Drugs · doi:10.1007/s40265-015-0452-4 · Cited by 50
Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation
Panikker, S., Lord, J. L., Jarman, J. W. E., Armstrong, S. O., Jones, D. G., Haldar, S., Butcher, C., Khan, H. R., Mantziari, L., Nicol, E., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw048 · Cited by 51

Authors: Friberg, L., Rosenqvist, M., & Lip, G. Y. H.
Affiliations: Danderyds sjukhus (SE)
Karolinska Institutet (SE)
Birmingham City Hospital (GB)
Corresponding author: Lip, Gregory Y.H.
ORCID: Friberg, Leif
Lip, Gregory Y.H.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2012-01-13
Volume: 33
Issue: 12
Pages: 1500-1510
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/ehr488
OpenAlex: W2124601103
Cited by: 1,192
References: 48
Citations by year: 2026: 37 · 2025: 60 · 2024: 74 · 2023: 81 · 2022: 112 · 2021: 99 · 2020: 100 · 2019: 99 · 2018: 78 · 2017: 99 · 2016: 75 · 2015: 99 · 2014: 72 · 2013: 68 · 2012: 35
FWCI: 56.38
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: Stockholms Läns Landsting
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: atrial fibrillation, stroke risk stratification, bleeding risk stratification, CHA2DS2-VASc score, HAS-BLED score, thromboembolism, intracranial hemorrhage, risk factors, peripheral arterial disease, oral anticoagulants, thyroid dysfunction, hyperthyroidism, concordance index
MeSH terms: Adult, Aged, Anticoagulants, Atrial Fibrillation, Female, Hemorrhage, Humans, Male, Middle Aged, Risk Factors, Sweden, Thromboembolism, Cohort Studies, Risk Assessment, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks